GlaxoSmithKline's Shingrix Approved in the U.S. for Prevention of Shingles in Adults Aged 50 and … Post author:Sam Post published:October 22, 2017 Post category:BioPharma Shingrix is a non-live, recombinant subunit vaccine given intramuscularly in two doses. Source: BioSpace You Might Also Like GE Healthcare to Shutter Maryland Plant, Nearly 200 Employees Affected February 6, 2017 Sources Reveal Biogen is Exploring Sale of Hemophilia Assets April 11, 2016 7 Biotechs and Pharmas That Have the Potential to Double (or More) May 31, 2017
